Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
SelectedYTD Return
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | MRNA | AMGN |
|---|---|---|
| Return | ||
| Last Price | 145.00 | 415.26 |
| Daily Change | − 2.60% | − 6.50% |
| Period ReturnYear to Date | + 371.65% | + 33.45% |
| Valuation | ||
| Market Cap | $57.5 B | $224 B |
| P/E Ratio | — | 25.79 |
| Dividend Yield | — | 3.21% |
| Net MarginTrailing 12M | — | 23.0% |
| Risk | ||
| Beta | — | 0.45 |
| 52-Week Range | — | 269.77 — $447.03 |
| Company | ||
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology |
Company
- MRNAHealth Care · Biotechnology
- AMGNHealth Care · Biotechnology
Metrics could not be loaded for MRNA: P/E, dividend, beta and the 52-week range stay empty in that column.
Alpaca · SIPUpdated 02:5515 Minutes Delayed
To Understand This